{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:20:21Z","timestamp":1792693221843,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1928,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/modpathol.2017.61","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T07:41:11Z","timestamp":1498203671000},"page":"1422-1432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":186,"title":["SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior"],"prefix":"10.1016","volume":"30","author":[{"given":"Jennifer L","family":"Sauter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-4867","authenticated-orcid":false,"given":"Rondell P","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon T","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.61_bib1","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1101\/gad.10.17.2117","article-title":"Diversity and specialization of mammalian SWI\/SNF complexes","volume":"1","author":"Wang","year":"1996","journal-title":"Genes Dev"},{"key":"10.1038\/modpathol.2017.61_bib2","first-page":"6171","article-title":"BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines","volume":"60","author":"Wong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.61_bib3","doi-asserted-by":"crossref","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","article-title":"The spectrum of SWI\/SNF mutations, ubiquitous in human cancers","volume":"8","author":"Shain","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1038\/modpathol.2017.61_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2017.61_bib5","doi-asserted-by":"crossref","first-page":"e1500447","DOI":"10.1126\/sciadv.1500447","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics","volume":"1","author":"Kadoch","year":"2015","journal-title":"Sci Adv"},{"key":"10.1038\/modpathol.2017.61_bib6","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1073\/pnas.91.8.2905","article-title":"Five SWI\/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement","volume":"91","author":"Peterson","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2017.61_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2017.61_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jjco\/hyt101","article-title":"Inactivating mutations in SWI\/SNF chromatin remodeling genes in human cancer","volume":"43","author":"Oike","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1038\/modpathol.2017.61_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2017.61_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2017.61_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2017.61_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","article-title":"SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas","volume":"39","author":"Karanian-Philippe","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.61_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/his.12988","article-title":"Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics","volume":"69","author":"Clarke","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2017.61_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/PAS.0000000000000558","article-title":"Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type","volume":"40","author":"Conlon","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.61_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PAS.0b013e3182196a39","article-title":"Nonsense mutation and inactivation of SMARCA4 (BRG1) in an Atypical Teratoid\/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression","volume":"35","author":"Hasselblatt","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.61_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","article-title":"Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant","volume":"19","author":"Strehl","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/modpathol.2017.61_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/his.12989","article-title":"Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1\/INI1-deficient tumours","volume":"69","author":"Hoang","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2017.61_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","article-title":"SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"10.1038\/modpathol.2017.61_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.61_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.humpath.2006.12.003","article-title":"Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium","volume":"38","author":"Donner","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.61_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.61_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.61_bib23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2017.61_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/modpathol.2017.61_bib25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cas.12065","article-title":"Lung cancer with loss of BRG1\/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features","volume":"104","author":"Matsubara","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1038\/modpathol.2017.61_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pin.12350","article-title":"Frequent loss of the expression of multiple subunits of the SWI\/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung","volume":"65","author":"Yoshimoto","year":"2015","journal-title":"Pathol Int"},{"key":"10.1038\/modpathol.2017.61_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0000000000000038","article-title":"The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotype, biological, and molecular heterogeneity","volume":"21","author":"Agaimy","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2017.61_bib28","first-page":"3461","article-title":"Alterations of the hSNF5\/INI1 gene in central nervous system atypical teratoid\/rhabdoid tumors and renal and extrarenal rhabdoid tumors","volume":"8","author":"Biegel","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.61_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/modpathol.3800375","article-title":"INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas","volume":"18","author":"Perry","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.61_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12632","article-title":"Frequent co-inactivation of the SWI\/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours","volume":"67","author":"Rao","year":"2015","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2017.61_bib31","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-08-2091","article-title":"Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1\/SMARCB1 in malignant rhabdoidtumors","volume":"15","author":"Jackson","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.61_bib32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/01.pas.0000141390.14548.34","article-title":"Immunohistochemical analysis of hSNF5\/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors","volume":"28","author":"Hoot","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.61_bib33","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/PAS.0000000000000173","article-title":"SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review","volume":"38","author":"Agaimy","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.61_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.2014.100","article-title":"Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes","volume":"28","author":"Agaimy","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.61_bib35","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.humpath.2014.06.027","article-title":"Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI\/SNF complex members to pathogenesis","volume":"45","author":"Li","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.61_bib36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/PAS.0b013e3181882c54","article-title":"Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma","volume":"33","author":"Hornick","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.61_bib37","unstructured":"A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed\/refractory synovial sarcoma - Full Text View - ClinicalTrials.gov. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02601950?term=EZH2&rank=1&show_locs=Y#locn. Accessed March 2 2017."},{"key":"10.1038\/modpathol.2017.61_bib38","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/sj.onc.1208716","article-title":"The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential","volume":"24","author":"Yamamichi","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2017.61_bib39","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","article-title":"The reversible epigenetic silencing of BRM: implications for clinical targeted therapy","volume":"26","author":"Glaros","year":"2007","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2017.61_bib40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/onc.2012.613","article-title":"Identifying targets for the restoration and reactivation of BRM","volume":"33","author":"Kahali","year":"2014","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2017.61_bib41","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1038\/onc.2011.80","article-title":"Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy","volume":"30","author":"Gramling","year":"2011","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2017.61_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/157018011793663840","article-title":"Discovery of BRM targeted therapies: novel reactivation of an anti-cancer gene","volume":"8","author":"Gramling","year":"2011","journal-title":"Lett Drug Des Discov"},{"key":"10.1038\/modpathol.2017.61_bib43","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/carcin\/bgu117","article-title":"Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids","volume":"35","author":"Kahali","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1038\/modpathol.2017.61_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/modpathol.2015.129","article-title":"Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type","volume":"29","author":"Jelinic","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.61_bib45","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.humpath.2010.11.010","article-title":"SOX2 amplification is a common event in squamous cell carcinomas of different organ sites","volume":"42","author":"Maier","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.61_bib46","first-page":"172","article-title":"The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung","volume":"2","author":"Karachaliou","year":"2013","journal-title":"Transl Lung Cancer Res"},{"key":"10.1038\/modpathol.2017.61_bib47","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/PAI.0b013e31826fd4f3","article-title":"Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas","volume":"21","author":"Masai","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2017.61_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PAI.0b013e3182980544","article-title":"p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: comparison with p63, cytokeratin 5\/6, desmocollin-3, and sox2","volume":"22","author":"Tatsumori","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2017.61_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.2016.230","article-title":"Claudin-4 expression distinguishes SWI\/SNF complex-deficient undifferentiated carcinomas from sarcomas","volume":"30","author":"Schaefer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.61_bib50","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/1078-0432.CCR-03-0489","article-title":"Chromatin remodeling factors and BRM\/BRG1 expression as prognostic indicators in non-small cell lung cancer","volume":"10","author":"Fukuoka","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.61_bib51","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.61_bib52","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/1078-0432.CCR-15-1468","article-title":"SMARCA4\/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancer","volume":"22","author":"Bell","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.61_bib53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/hupa.2001.28252","article-title":"Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?","volume":"32","author":"Fuller","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.61_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3393\/ac.2013.29.6.252","article-title":"Rhabdoid carcinoma of the rectum","volume":"29","author":"Samalavicius","year":"2013","journal-title":"Ann Coloproctology"},{"key":"10.1038\/modpathol.2017.61_bib55","first-page":"233","article-title":"Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion","volume":"12","author":"Wick","year":"1995","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/modpathol.2017.61_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pathol.2015.11.020","article-title":"BRG1-deficient dedifferentiated endometrioid adenocarcinoma of the ovary","volume":"48","author":"Tan","year":"2016","journal-title":"Pathology"},{"key":"10.1038\/modpathol.2017.61_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00428-016-1977-y","article-title":"Loss of expression of the SWI\/SNF complex is a frequent event in undifferentiated\/dedifferentiated urothelial carcinoma of the urinary tract","volume":"469","author":"Agaimy","year":"2016","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1038\/modpathol.2017.61_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1746-1596-8-31","article-title":"Right-sided rhabdoid colorectal tumors might be related to the serrated pathway","volume":"8","author":"Pancione","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1038\/modpathol.2017.61_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2017.61_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2017.61_bib61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1535-7163.MCT-16-0678","article-title":"Selective killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2: in vitroin vivo preclinical models","volume":"16","author":"Chan-Penebre","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/modpathol.2017.61_bib62","unstructured":"Januario T, Ye X, Bainer R et al, PRC2 mediated repression of SMARCA2 predicts for EZH2 inhibitor activity in tumors with SWI\/SNF mutations. Available from www.abstractsonline.com\/pp8\/#!\/4292\/presentation\/1610."},{"key":"10.1038\/modpathol.2017.61_bib63","unstructured":"Rzymski T, Wrobel A, Mikula M et al, Epigenetic modulators show differential activity on lung adenocarcinoma cells with loss-of-function mutations of SWI\/SNF protein SMARCA4. Available from www.abstractsonline.com\/pp8\/#!\/4292\/presentation\/3803."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201761","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:46:10Z","timestamp":1760229970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522201242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S089339522201242X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.61","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.61","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}